POOJA LAWANSHI’s Post

𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚: 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐑𝐚𝐩𝐢𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 🌟 ✅ 𝗚𝗿𝗮𝗯 𝗣𝗗𝗙 𝗙𝗼𝗿 𝗠𝗼𝗿𝗲 𝗗𝗲𝘁𝗮𝗶𝗹𝘀 >>https://lnkd.in/e9MSB9aE Continuous bioprocessing is transforming the pharmaceutical and biopharma sectors with its cutting-edge technology and data-driven processes. According to Meticulous Research®, the Continuous Bioprocessing Market is expected to grow at a CAGR of 19.6%, reaching $1.32 billion by 2031. 💡 𝐆𝐫𝐨𝐰𝐭𝐡 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 1. Adoption of Process Analytical Technology (PAT) is enhancing real-time monitoring and efficiency in continuous manufacturing. 2. Increasing demand for monoclonal antibodies (mAbs), vaccines, and plasma fractionation is driving innovation. 3. Significant investments and expansions, such as Eli Lilly’s $452 million investment in monoclonal antibody production. 4. Asia-Pacific expected to register the highest CAGR, with China leading the way in pharmaceutical and biopharmaceutical advancements. 📊 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: *𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬:Filtration Systems, Chromatography, Bioreactors, Incubators, Centrifuges, Reagents, and more. *𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐓𝐲𝐩𝐞𝐬: Upstream and Downstream. *𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:mAbs production, Vaccine Manufacturing, Plasma Fractionation, Cell & Gene Therapy, R&D. *𝐄𝐧𝐝 𝐔𝐬𝐞𝐫𝐬:Pharmaceutical & Biotechnology Companies, CDMOs, CROs, Academic Institutes. 🏢 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: 3M ,Thermo Fisher Scientific, Sartorius ,Merck Group ,Danaher Corporation #ContinuousBioprocessing #Biopharma #PharmaceuticalInnovation #PAT #MonoclonalAntibodies #VaccineManufacturing #MarketResearch #PharmaTech #BiotechGrowth #GlobalBioprocessing   ➡𝐑𝐞𝐚𝐥𝐭𝐞𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:   1. 𝐀𝐬𝐢𝐚 𝐩𝐚𝐜𝐢𝐟𝐢𝐜 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 : https://lnkd.in/eCt6GxRD 2. 𝐄𝐮𝐫𝐨𝐩𝐞 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/eiYYbesw

📢 Revolutionizing Cell Culture Automation with Raman Spectroscopy Raman spectroscopy is a valuable tool for analyzing cell cultures in biopharmaceutical manufacturing. It allows for rapid, non-destructive measurement of multiple components. The technique can help optimize processes, improve product quality, and reduce costs. However, there are still challenges to overcome, such as accurately quantifying low-concentration substances. Automation of feeding based on Raman spectroscopy is an ongoing area of research. Overall, Raman spectroscopy is expected to play a larger role in automating cell culture processes. 🧪🔬✨ #BioprocessUpdates #RamanSpectroscopy #CellCulture #Biopharmaceuticals #Manufacturing #ProcessOptimization #ProductQuality #CostReduction #Automation #Feeding #Quantification #LowConcentration #Research #Technology #Biotech #ScientificAdvancements ▷ Read the full article here: 📎 https://lnkd.in/dBwfEuuZ

Small Molecules vs Biologics in Pharma 💊🧬 Small Molecules ⚗️ - Small molecules are simple chemical compounds with low molecular mass. Due to their small size, they can easily penetrate cells and reach intracellular targets, and can often be administered orally and topically. - Advantages : *Easier production and quality control. *Can often be administered orally and topically. *Affordable generics are widely available. - Disadvantages: *Less specific, with risks of off-target effects. *More likely to have drug-drug interactions. Biologics 💉 - Biologics are much larger and more complex molecules, derived from living organisms (peptides, enzymes, antibodies ...). However, they often must be administered via injection or infusion and require more complex production processes. Advantages: *High specificity, reducing the risk of off-target effects. *Effective for difficult to treat diseases. Disadvantages: *Higher production costs. *Increased risk of immune reactions. *Stricter storage conditions required. If you’d like to learn more about these two approaches, feel free to comment and share this post ! 👇 📩 #Chemistry #Pharma #Biologics #SmallMolecules #Innovation #DrugDevelopment

Echelon Biosciences continues to lead the way in biochemical reagents, assays, and peptides customized for academic research and pharmaceutical development. With a strong focus on advancing the science of lipid signaling, Echelon’s innovative research tools are designed to pave the way for drug treatments and diagnostics for debilitating diseases. As the sole distributor of Echelon Biosciences in India, BTL Biotechno Labs Pvt Ltd is excited to introduce their newly launched Glycolipids for LNPs! ✨6,6′-Trehalose Dioleate Glycolipids can play a role in decreasing LNP toxicity. It can form hydrogen bonds with polar biomolecules, allowing the formation of a stable LNP structure by partially replacing the ionizable lipid. It can facilitate the development of mRNA vaccines with improved clinical safety. ✨6-Trehalose Monooleate can be used as antiaggregation agent for stabilization of proteins. It can also be used as a delivery vehicle for topical drugs by forming solid lipid nanoparticles. For more product specifications, please connect with us at info@biotechnolabs.com. Echelon Biosciences Cameron Day, Ph.D Paul Neilsen Colin Ferguson #LipidSignaling #Glycolipids #LNP #mRNAVaccine #PharmaResearch #DrugDevelopment #Biotech #EchelonBioscience #BTLBiotechnoLabsPvtLtd

I'm thrilled to share that I secured the FIRST position in National Conference on ‘Artificial Intelligence Driven Paradigms in Drug Discovery and Pharmaceutical Research' for presenting a poster on "Addressing Aggregation Challenges in Biologic Formulations: Amino Acid-based Strategies for Insulin and IFN-β Stability" at Baba Farid University of Health Sciences, Faridkot (Punjab). This achievement represents a significant milestone in our ongoing efforts to enhance the stability and efficacy of biologic formulations, particularly for insulin and interferon-beta. The research focuses on innovative amino acid-based strategies to combat protein aggregation, a critical challenge in the development and storage of these therapeutic proteins. Looking forward to continuing this journey of innovation and discovery in the field of biologics! #BiologicFormulations #InsulinStability #InterferonBeta #ProteinAggregation #ResearchAchievement #ScienceInnovation #ProudMoment

Global #3D_Cell_Culture_Microplates Market Poised for Significant Growth as Biotechnology Advances >> https://lnkd.in/ePxnpS8Q 3D #cell culture microplate is a next-generation #tool of choice for safety pharmacology and #drug screening purposes. It is designed to support the growth, #attachment, and differentiation of cells for ongoing #culture or temporarily before cell-based #assays. It is widely used in CROs, #biotech, pharmaceutical #companies, and fundamental #research in academic and government #laboratories. eNUVIO - Microfabricated Devices for Next-generation Cell Culture Creative Bioarray Biotek Ortho Thermo Fisher Scientific InSphero Biocroi Limited #healthcareindustry #pharmaceuticalindustry #healthcareresearch #biotechnology #3Dcell #culture #discovery #research 

📢 Revolutionary Guidelines Transform Biologics Screening Process! 🧪 U.S. researchers set new guidelines for 96-well plate chromatography experiments. 🔬 Developed by the University of Virginia, these standards aim to enhance consistency and quality in biologics screening. 📈 The goal is to help companies achieve reliable results across departments, aiding comparison in the industry. 💻 A supportive software package is released for experimental design, applicable to various protein-based products. #BioprocessUpdates #BiologicsScreening #PlateBasedBiologics #Chromatography #ResearchInnovation #UVA #QualityStandards #LifeSciences #ProteinResearch #LaboratoryTech #ExperimentalDesign #Biotech #ResearchCommunity #ConsistentResults #ScientificGuidelines #Biopharmaceuticals ▷ Read the full article here: 📎 https://lnkd.in/dpbsnE8V

🔬 Optimizing Bioproduction with HCP-Profiler and READYBEADS 🔬 Accurate Host Cell Protein (HCP) analysis is crucial during the scale-up of bioproduction. Anaquant’s HCP-Profiler, powered by READYBEADS technology, enables precise identification and quantification of HCPs across different batches, even when produced months apart. This ensures the consistency and safety of biologic products, helping pharma and biotech companies maintain high standards in drug quality and efficacy. 🔍 Key Benefits: -Accurate HCP profiling for process scaling -Reliable data with universal calibration curves Learn more here: https://lnkd.in/gQpNTMCf #Biotech #Biopharma #HCPAnalysis #READYBEADS #Innovation

A Complete Guide of "𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 "- [ Get Glimpse Insights ]  ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅>>https://lnkd.in/eukbrFCM #Continuousbioprocessing is increasingly being adopted due to its agility, flexibility, efficiency, and robustness. This approach streamlines processes by minimizing steps, utilizing compact facilities and equipment, and enhancing product quality to facilitate real-time release. #Continuousbioprocessing market in Asia-Pacific is attributed to the gradual adoption of continuous manufacturing, rising manufacturing and research-related outsourcing of biopharmaceuticals, expansions in #CDMOs, and initiatives supporting the adoption of #biopharmaceuticals. 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 ➮Chromatography Systems and Consumables ➮Cell Culture Media, Buffers, and Reagents ➮Incubators and Shakers ➮Filtration Systems and Consumables ➮Bioreactors Growing initiatives supporting the adoption of biopharmaceuticals, rising biopharmaceutical manufacturing outsourcing, growing investments in constructing facilities compatible with #continuousbioprocessing for the commercial manufacture of #biopharmaceuticals, and accelerated developments in personalized therapies drive the adoption of continuous bioprocessing for commercial application. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:  Electrolab Biotech Limited (U.K.), Biowest (France), and Bionet (U.S.). Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands) #antibodies #cdmo #biopharmaceuticals #celltherapy #genetherapy #lifesciences #Continuousbioprocessing #Filtration, #Chromatography #Centrifuges #Consumables #Vaccines #Monoclonal #Antibodies #Pharmaceuticals #Biotechnology #CROs #healthcare #Continuousbioprocessingmarket #CDMOs ➡𝐑𝐞𝐚𝐥𝐭𝐞𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:  1.𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/eDTAycCa  2. 𝐄𝐮𝐫𝐨𝐩𝐞 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/eNFMiUhX

#research We’re thrilled to announce our latest paper: "Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective." This paper delves into the transformative potential of #lipid-based #nanoformulations for improving #drug solubility, stability, and targeted #delivery, addressing a critical challenge in pharmaceutical sciences. In This Review: 💧 Enhanced Solubility: Exploring how lipids help dissolve water-insoluble drugs. ⚖️ Formulation Types: Microemulsions, nanoemulsions, and self-emulsifying drug systems. 🧊 Controlled Release: The introduction of solid-phase lipids to minimize drug leakage and extend release times. 🧬 Therapeutic Potential: Leveraging nanoparticles for therapeutic agents like proteins, nucleic acids, and vaccines. 🎯 Targeted Delivery: Advances in targeting ligands and synthetic lipids for precision drug delivery. 📄 Authors: Mubashar Rehman, Nayab Tahir, Muhammad Farhan Sohail Muhammad Usman Qadri, Sofia Duarte, Pedro Brandão Teresa Esteves, Ibrahim Javed, Pedro Fonte 🔗 https://lnkd.in/dceBTrtq This paper was published as part of the special issue "Liposomes Applied in Drug Delivery Systems," edited by Pedro Fonte, Teresa Esteves, and Sofia Duarte. We extend our gratitude to everyone involved in making this publication possible. Stay tuned for more cutting-edge insights from our lab at the forefront of biopharmaceutical research! #PharmaceuticalScience #DrugDelivery #Nanoformulations #LipidNanoparticles #Research #Biotechnology #PedroFonteGroup